Artivion Inc. Common Stock (AORT)

About AORT

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXU…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

1,800

Website

artivion.com/

Fundamentals

1-day range

$26.7$27.11

Market cap

$1.33B

P/E (trailing)

117.64

P/E (forward)

34.25

EPS (trailing)

$0.24

Dividend yield

—

Beta

1.22

Avg. volume

753.3K

Ex-dividend date

December 9, 2015

Forecasts

8 analyst ratings

Artivion Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• AORT

  Artivion Inc. Common Stock

  $26.78

  ▲ 0.39%
  Market cap $1.33BP/E 117.64
  $19.16$48.25
• IRMD

  iRadimed Corporation Common Stock

  $86.98

  ▼ 0.03%
  Market cap $1.17BP/E 48.23
  $67.84$107.9
• ATEC

  Alphatec Holdings Inc. Common Stock

  $9.43

  ▼ 1.46%
  Market cap $1.56BP/E —
  $6.82$23.29
• NVCR

  NovoCure Limited Ordinary Shares

  $17.8

  ▼ 1.08%
  Market cap $1.78BP/E —
  $9.82$21.45
• SSII

  SS Innovations International Inc. Common Stock

  $3.5

  ▲ 2.34%
  Market cap $790.52MP/E —
  $3.11$10
• TCMD

  Tactile Systems Technology Inc. Common Stock

  $23.15

  ▲ 0.17%
  Market cap $671.73MP/E 26.91
  $12.91$37.77
• BWAY

  BrainsWay Ltd. American Depositary Shares

  $14.29

  ▼ 0.76%
  Market cap $632.92MP/E 72.19
  $2,391$5,123

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40
  benzinga · 8/18/2026
• Canaccord Genuity Maintains Buy on Artivion, Raises Price Target to $40
  Benzinga · 8/18/2026
• Alger Dynamic Opportunities Fund Q2 2026 Portfolio Update
  SeekingAlpha · 8/9/2026
• Artivion, Inc. (AORT) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/7/2026
• Artivion, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/7/2026
• Artivion Affirms FY2026 Sales Guidance of $480.000M-$496.000M vs $486.232M Est
  Benzinga · 8/6/2026
• Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells
  SeekingAlpha · 8/4/2026

• Holloway Jean F · August 12, 2026 · Sale

  977 @ $28.49
• GREEN ANDREW M · June 11, 2026 · Option Exercise

  30.0K @ $11.03
• GREEN ANDREW M · June 11, 2026 · Option Exercise

  14.0K @ $18.44
• GREEN ANDREW M · June 11, 2026 · Sale

  30.0K @ $20.69
• GREEN ANDREW M · June 11, 2026 · Sale

  14.0K @ $20.71
• SEMEDO ANTHONY B. · June 2, 2026 · J

  6.3K
• Salveson Jon W · May 18, 2026 · Grant

  7.6K
• Burbank Jeffrey H · May 18, 2026 · Grant

  7.6K
• BEVEVINO DANIEL J · May 18, 2026 · Grant

  7.6K
• Bullock James · May 18, 2026 · Grant

  7.6K
• ACKERMAN THOMAS F · May 18, 2026 · Grant

  7.6K
• Borgstrom Marna P · May 14, 2026 · Grant

  7.8K
• Holloway Jean F · March 4, 2026 · Sale

  9.0K @ $38
• Stanton Marshall S. · March 3, 2026 · Sale

  2.1K @ $37.78
• Davis John E · March 3, 2026 · Sale

  4.6K @ $37.78

Institutional Ownership

March 31, 2026

Total shares held

42.93M

Total value held

$1.53B

Institutional holders

232